Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3
1 clinical trials · Condition
◉ Watch Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies (NCT01004224) | Novartis Pharmaceuticals | 2009-12-11 |
Track Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 automatically
Every clearance here is in the API, with alerts when new ones post.